share_log
Moomoo 24/7 ·  04/23 07:30

Lisata Therapeutics and Qilu Pharmaceutical Announce First Patient Treated in Qilu’s Phase 2 Trial in China of Lsta1 in Patients With Metastatic Pancreatic Ductal Adenocarcinoma

Lisata Therapeutics和齐鲁制药宣布齐鲁在中国开展的针对转移性胰腺导管腺癌患者Lsta1的2期试验中首位患者接受治疗

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发